A study published in the Journal of the American Medical Association showed that a daily multivitamin supplement withselenium significantly slows the advance of HIV among those withthe virus. The researchers tested 878 asymptomatic, HIV-infectedpeople over two years that had never taken antiretroviral medications.
The test subjects were split into four groups, with members of each receivingseparate medications—multivitamins, multivitamins plus selenium, selenium aloneor a placebo—for five years. The multivitamins contained vitamins B, C and E.
Those given multivitamins plus selenium experienced a 54 percent reduction inlow counts of a critical immunity cell factor (called CD4) compared to the placebogroup. This group also experienced a 44 percent reduction in other events known toaccompany the progression of HIV, including AIDS-related deaths.
The researchers concluded: “In antiviral, therapy-naive, HIV-infected adults,24-month supplementation with a single supplement containing multivitamins andselenium was safe and significantly reduced the risk of immune decline and morbidity.”